Available at bioinx.com, customers can now easily acquire X-Pure GelMA and X-Pure GelDAT gelatins in both technical and research grades, offering selections from 1 gram to 50 grams. This initiative is designed to facilitate the work of professionals in tissue engineering and biofabrication by providing easy access to these crucial biomaterials.

The Rousselot team, featuring Isabel Vanhecke, Kathleen Jacobs, Tanja Vervust, and Lies De Smedt, alongside the BIO INX team represented by Jasper Van Hoorick, Coralie Gréant, and Julie Schockaert, have jointly expressed their enthusiasm for this partnership. It streamlines the procurement process and ensures the delivery of high-quality gelatins necessary for advancing in the field of bioprinting and biofabrication.

Tanja Vervust, Rousselot Biomedical’s Global Director, highlighted the benefits of this collaboration, emphasizing that Rousselot’s research-grade X-Pure gelatins are functionally equivalent to GMP-grade gelatins. This similarity aids in reducing development variability and smoothing the path to clinical applications.

Jasper Van Hoorick, CEO of BIO INX, shared his excitement about incorporating Rousselot’s gelatin range into BIO INX’s diverse biomaterial portfolio. This expansion is aimed at offering a broader selection of standardized biomaterials, ensuring consistency, quality, and reliability - essential factors for achieving reproducible results in bioprinting and critical for clinical translation in the future.

While customers in need of larger volumes, custom gelatins, GMP grades, or specialized support services such as regulatory advice or technical assistance are encouraged to contact Rousselot directly, this online availability marks a significant milestone. It not only enhances the accessibility of high-grade biomaterials but also supports the broader mission of advancing research and development in the biomedical sector.